JN
JNJ
Johnson & Johnson
NYSEMarket Cap
P/E Ratio
15.80
Dividend Yield
3.02%
Volume
52W High
52W Low
Avg Volume
Financial Statements
What does this mean?Income statement, balance sheet, and cash flow over time
| Metric | |
|---|---|
No financial data available
Institutional Ownership
What does this mean?Top institutions holding JNJ
| Institution | Shares Held | Value | Date |
|---|---|---|---|
| Vanguard Group | 150,000,000 | $25,000,000,000 | Oct 2025 |
| BlackRock | 140,000,000 | $23,500,000,000 | Nov 2025 |
| State Street | 80,000,000 | $13,500,000,000 | Oct 2025 |
| Fidelity | 65,000,000 | $11,000,000,000 | Oct 2025 |
| Geode Capital | 35,000,000 | $5,900,000,000 | Oct 2025 |
ETF Holdings
What does this mean?Top ETFs holding JNJ
| ETF | Weight | Shares |
|---|---|---|
| QQQ | 8.50% | 18,210,749 |
| VGT | 6.20% | 8,958,576 |
| SPY | 4.50% | 14,882,377 |
| IVV | 4.20% | 49,681,509 |
| VOO | 3.80% | 5,420,403 |
Trade
Buy/Sell via broker links (affiliate).
Trading 212
Paper Trade
Save a buy/sell to your portfolio tracker (not a real trade).
Sign in
to save trades to your portfolio tracker.
Paper Orders
Limit/stop reminders, with optional bracket (take profit + stop loss).
Sign in
to place paper orders.
Price Alerts
Notify when JNJ crosses your target.
Sign in
to create alerts and sync them across devices.
Company Info
What does this mean?About
Johnson & Johnson researches, develops, manufactures, and sells health products, including pharmaceuticals, medical devices, and consumer products worldwide.
CEO
Joaquin Duato
Industry
Drug Manufacturers
Sector
Healthcare
Employees
152,700
IPO Date
Sep 22, 1944
Website
Visit Website →
Analyst Ratings
What does this mean?Morgan Stanley
Dec 9, 2025
Hold
Piper Sandler
Dec 7, 2025
Buy
Goldman Sachs
Dec 6, 2025
Hold
Morgan Stanley
Nov 27, 2025
Hold
Morgan Stanley
Nov 19, 2025
Overweight
Bernstein
Nov 14, 2025
Overweight
JPMorgan
Nov 2, 2025
Buy
Piper Sandler
Nov 1, 2025
Buy
Goldman Sachs
Oct 23, 2025
Hold
Piper Sandler
Oct 22, 2025
Buy
Price Target
$145.81